作者: Molly Taylor
DOI: 10.3390/BIOMEDICINES3040270
关键词:
摘要: The realization of personalized medicine for cancer will rely not only on the development new therapies, but biomarkers that direct these therapies to right patient. MicroRNA expression profiles in primary tumor have been shown differ between patients and healthy individuals, suggesting they might make useful biomarkers. However, examination microRNA requires an invasive biopsy procedure. More recently, microRNAs be released from into circulation where can utilized as non-invasive diagnose patients, predict prognosis, or indicate therapeutic response. This review provides overview current use circulating well recent findings their role regulating cell signaling interactions microenvironment.